Post by Verily Health

The average study activation time is 9.4 months. That’s nearly triple the NCI’s 90-day target. The gap isn’t from a lack of study site effort. It’s due to complexity. In our latest Verily Viewpoint Study Start Up blog, we break down the hidden costs of delayed trial start up at AMCs and IDNs, and outline how these enterprise research sites can bring efficiency-driving structure, visibility, and predictability to activation. Read it now: https://veri.ly/4dZqfmO #ClinicalTrials #ClinicalResearch #HealthTech